{"id":2550,"date":"2023-02-07T20:56:16","date_gmt":"2023-02-07T23:56:16","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/"},"modified":"2023-02-07T20:56:16","modified_gmt":"2023-02-07T23:56:16","slug":"parse-biosciences-anuncia-evercode-tcr-e-genecapture","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/","title":{"rendered":"Parse Biosciences anuncia Evercode TCR e GeneCapture"},"content":{"rendered":"

(REUNI\u00c3O GERAL AGBT) \u2014 <\/b>Parse Biosciences<\/a>, importante fornecedora de solu\u00e7\u00f5es escalon\u00e1veis e acess\u00edveis de sequenciamento de c\u00e9lulas \u00fanicas, anunciou hoje a disponibilidade do Evercode\u2122 TCR e GeneCapture. Essas duas novas solu\u00e7\u00f5es ampliam o portf\u00f3lio da Parse Biosciences para tratamento de aplica\u00e7\u00f5es de escalas mais altas e perfis imunes.\n<\/p>\n

\nO Evercode TCR permite aos pesquisadores delinear receptores de c\u00e9lulas T (TCR) juntamente com transcriptomas totais em c\u00e9lulas \u00fanicas em escala. A diversidade de poss\u00edveis TCRs no repert\u00f3rio imune \u00e9 enorme, mas, apesar disso, a baixa produtividade das ferramentas existentes limitou a capacidade de capturar essa complexidade em alta resolu\u00e7\u00e3o. O Evercode TCR permitir\u00e1 aos pesquisadores medir todas as transcriptomas e sequ\u00eancias pareadas de TCR, tanto cadeias alpha quanto beta, em at\u00e9 1 milh\u00e3o de c\u00e9lulas. A combina\u00e7\u00e3o de sequ\u00eancias de TCR com express\u00e3o g\u00eanica nessa escala permite rastrear os cronotipos de TCR em diferentes subtipos de c\u00e9lulas T e estados de ativa\u00e7\u00e3o para compreender o repert\u00f3rio imune em excepcional resolu\u00e7\u00e3o.\n<\/p>\n

\nA Parse tamb\u00e9m anunciou o lan\u00e7amento do GeneCapture, uma solu\u00e7\u00e3o para reduzir a necessidade de sequenciamento para estudos maiores. O GeneCapture concentra o sequenciamento nos genes mais relevantes, possibilitando dimensionar projetos com efici\u00eancia para milh\u00f5es de c\u00e9lulas e centenas de amostras. A solu\u00e7\u00e3o permite aos pesquisadores enriquecer para 100s-1000s de genes, exigindo 10 vezes menos sequenciamento. Os pesquisadores podem solicitar um painel pr\u00e9-projetado de aproximadamente 1.000 genes relevantes para imunologia, o Immnune 1000, ou desenvolver um painel exclusivo para suas necessidades.\n<\/p>\n

\n\u201cCada vez mais, vemos a necessidade de apoiar estudos maiores de sequenciamento de RNA de c\u00e9lulas \u00fanicas. A Biologia \u00e9 complexa e exige estudos rebustos em diversas amostras, pontos no tempo e muitas c\u00e9lulas individuais para capturar totalmente essa complexidade”, observa o cofundador e CEO da Parse, Alex Rosenberg, Ph.D. “A tecnologia da Parse j\u00e1 trouxe escala sem precedentes ao mercado, e essas novas ferramentas ampliar\u00e3o esses recursos, desbloqueando novas aplica\u00e7\u00f5es tanto na pesquisa quanto no espa\u00e7o translacional”.\n<\/p>\n

\nCharles Roco, Ph.D., cofundador e CTO da Parse, fara uma apresenta\u00e7\u00e3o sobre os recursos dos produtos Evercode TCR e GeneCapture, da Parse, na Reuni\u00e3o Geral AGBT esta semana na sua sess\u00e3o. Ampliando o acesso para o sequenciamento de c\u00e9lulas \u00fanicas escalon\u00e1vel<\/b>,\u201d quarta-feira, 8 de fevereiro, \u00e0s 13:35, no Grand Ballroom<\/b>.\n<\/p>\n

\nPara saber mais sobre o enriquecimento do Evercode TCR e o GeneCapture, visite www.parsebiosciences.com<\/a>.\n<\/p>\n

Sobre a Parse Biosciences<\/b><\/p>\n

\nA Parse Biosciences \u00e9 uma empresa baseada em Seattle com a miss\u00e3o de acelerar o progresso da sa\u00fade humana e a pesquisa cient\u00edfica. No centro da nossa empresa est\u00e1 nossa abordagem pioneira de sequenciamento de c\u00e9lulas \u00fanicas. O sequenciamento de c\u00e9lulas \u00fanicas j\u00e1 permitiu descobertas inovadoras, que t\u00eam levado a um novo entendimento sobre o tratamento do c\u00e2ncer, reparo de tecidos, terapia com c\u00e9lulas- tronco, doen\u00e7as renais e hep\u00e1ticas, desenvolvimento cerebral e o sistema imune. Na Parse Biosciences, estamos fornecendo aos pesquisadores a capacidade de realizar sequenciamento de c\u00e9lulas \u00fanicas em escala e com facilidade sem precedentes. Para saber mais, acesse https:\/\/www.parsebiosciences.com\/<\/a>.\n<\/p>\n

\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.\n<\/p>\n

\"\"<\/span><\/p>\n

Ver a vers\u00e3o original em businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230207005623\/pt\/<\/a><\/span><\/p>\n

Contato:<\/b><\/p>\n

\nJay Roberts, SRPR\n<\/p>\n

jay@shevrushpr.com<\/a> | 917.696.2142\n<\/p>\n

Fonte: <\/strong>BUSINESS WIRE<\/a>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

(REUNI\u00c3O GERAL AGBT) \u2014 Parse Biosciences, importante fornecedora de solu\u00e7\u00f5es escalon\u00e1veis e acess\u00edveis de sequenciamento de c\u00e9lulas \u00fanicas, anunciou hoje a disponibilidade do Evercode\u2122 TCR e GeneCapture. Essas duas novas solu\u00e7\u00f5es ampliam o portf\u00f3lio da Parse Biosciences para tratamento de aplica\u00e7\u00f5es de escalas mais altas e perfis imunes. O Evercode TCR permite aos pesquisadores delinear […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-2550","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"\nParse Biosciences anuncia Evercode TCR e GeneCapture - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Parse Biosciences anuncia Evercode TCR e GeneCapture - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"(REUNI\u00c3O GERAL AGBT) \u2014 Parse Biosciences, importante fornecedora de solu\u00e7\u00f5es escalon\u00e1veis e acess\u00edveis de sequenciamento de c\u00e9lulas \u00fanicas, anunciou hoje a disponibilidade do Evercode\u2122 TCR e GeneCapture. Essas duas novas solu\u00e7\u00f5es ampliam o portf\u00f3lio da Parse Biosciences para tratamento de aplica\u00e7\u00f5es de escalas mais altas e perfis imunes. O Evercode TCR permite aos pesquisadores delinear […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-07T23:56:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"Parse Biosciences anuncia Evercode TCR e GeneCapture\",\"datePublished\":\"2023-02-07T23:56:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/\"},\"wordCount\":614,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/\",\"name\":\"Parse Biosciences anuncia Evercode TCR e GeneCapture - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp\",\"datePublished\":\"2023-02-07T23:56:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Parse Biosciences anuncia Evercode TCR e GeneCapture\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Parse Biosciences anuncia Evercode TCR e GeneCapture - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/","og_locale":"pt_BR","og_type":"article","og_title":"Parse Biosciences anuncia Evercode TCR e GeneCapture - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"(REUNI\u00c3O GERAL AGBT) \u2014 Parse Biosciences, importante fornecedora de solu\u00e7\u00f5es escalon\u00e1veis e acess\u00edveis de sequenciamento de c\u00e9lulas \u00fanicas, anunciou hoje a disponibilidade do Evercode\u2122 TCR e GeneCapture. Essas duas novas solu\u00e7\u00f5es ampliam o portf\u00f3lio da Parse Biosciences para tratamento de aplica\u00e7\u00f5es de escalas mais altas e perfis imunes. O Evercode TCR permite aos pesquisadores delinear […]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2023-02-07T23:56:16+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"Parse Biosciences anuncia Evercode TCR e GeneCapture","datePublished":"2023-02-07T23:56:16+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/"},"wordCount":614,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/","name":"Parse Biosciences anuncia Evercode TCR e GeneCapture - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp","datePublished":"2023-02-07T23:56:16+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230207005623r1&sid=brdno&distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/parse-biosciences-anuncia-evercode-tcr-e-genecapture\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"Parse Biosciences anuncia Evercode TCR e GeneCapture"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/2550","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=2550"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/2550\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=2550"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=2550"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=2550"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}